[Clinical evaluation of a new hypotensive drug combination]. 1977

P L Castillo Higueras, and A Rodríguez Cuartero, and F Rodríguez Cuartero, and F Urbano Jiménez, and J Peláez Redondo

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011437 Propylamines Derivatives of propylamine (the structural formula NH2CH2CH2CH3).
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002740 Chlorothiazide A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p812)
D003000 Clonidine An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION. Catapres,Catapresan,Catapressan,Chlophazolin,Clofelin,Clofenil,Clonidine Dihydrochloride,Clonidine Hydrochloride,Clonidine Monohydrobromide,Clonidine Monohydrochloride,Clopheline,Dixarit,Gemiton,Hemiton,Isoglaucon,Klofelin,Klofenil,M-5041T,ST-155,Dihydrochloride, Clonidine,Hydrochloride, Clonidine,M 5041T,M5041T,Monohydrobromide, Clonidine,Monohydrochloride, Clonidine,ST 155,ST155
D003508 Cycloheptanes Seven-carbon cycloparaffin cycloheptane (the structural formula (CH2)7) and its derivatives.
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation

Related Publications

P L Castillo Higueras, and A Rodríguez Cuartero, and F Rodríguez Cuartero, and F Urbano Jiménez, and J Peláez Redondo
August 1963, Gazzetta medica italiana,
P L Castillo Higueras, and A Rodríguez Cuartero, and F Rodríguez Cuartero, and F Urbano Jiménez, and J Peláez Redondo
February 1970, Polski tygodnik lekarski (Warsaw, Poland : 1960),
P L Castillo Higueras, and A Rodríguez Cuartero, and F Rodríguez Cuartero, and F Urbano Jiménez, and J Peláez Redondo
August 1964, Journal of the Medical Association of the State of Alabama,
P L Castillo Higueras, and A Rodríguez Cuartero, and F Rodríguez Cuartero, and F Urbano Jiménez, and J Peláez Redondo
April 1967, Journal des sciences medicales de Lille,
P L Castillo Higueras, and A Rodríguez Cuartero, and F Rodríguez Cuartero, and F Urbano Jiménez, and J Peláez Redondo
April 1969, Hospital (Rio de Janeiro, Brazil),
P L Castillo Higueras, and A Rodríguez Cuartero, and F Rodríguez Cuartero, and F Urbano Jiménez, and J Peláez Redondo
July 1957, Gazzetta medica italiana,
P L Castillo Higueras, and A Rodríguez Cuartero, and F Rodríguez Cuartero, and F Urbano Jiménez, and J Peláez Redondo
October 1955, The American journal of the medical sciences,
P L Castillo Higueras, and A Rodríguez Cuartero, and F Rodríguez Cuartero, and F Urbano Jiménez, and J Peláez Redondo
December 1982, La Clinica terapeutica,
P L Castillo Higueras, and A Rodríguez Cuartero, and F Rodríguez Cuartero, and F Urbano Jiménez, and J Peláez Redondo
May 1977, Kardiologiia,
P L Castillo Higueras, and A Rodríguez Cuartero, and F Rodríguez Cuartero, and F Urbano Jiménez, and J Peláez Redondo
January 1962, Kardiologiia,
Copied contents to your clipboard!